Church & Dwight Takes Homeopathic Turn For OTC Sales Driver, Acquires Zicam Marketer Matrixx

 
• By Eileen Francis

C&D CEO Matthew Farrell says Zicam has 73% share in the US zinc-containing wellness product market. It's acquiring marketer Matrixx Initiatives at a price almost 15 times Zicam brand’s projected 2021 EBITDA.

Around 90% of Zicam's sales, forecast in 2021 at $90m, are generated by RapidMelts and nasal swabs. (SAAM GABBAY)

More from Deals

More from Business